Literature DB >> 22736038

[Low flow/low gradient aortic valve stenosis : clinical and diagnostic management].

S Herrmann1, M Niemann, S Störk, K Hu, W Voelker, G Ertl, F Weidemann.   

Abstract

Low gradient aortic stenoses (AS) represent a special challenge for physicians with respect to an exact diagnosis and optimal therapy. The difficulty lies in the estimation of the severity of AS which is decisive for subsequent treatment and the prognosis. Low flow and low gradient can be due to systolic or diastolic dysfunction by high-grade as well as by medium-grade AS and be of non-valvular origin. The latter group is to be interpreted as pseudoaortic stenosis as long as the low flow can successfully be raised by interventional means. However, only patients in the first group can be expected to profit from valve replacement and for patients in the second group the accompanying diseases must be the focus of therapeutic treatment. Therefore, according to recent European surveys up to 30% of patients with severe AS are undertreated due to false estimation of the severity of stenosis and perioperative risk stratification. Furthermore, follow-up investigations have shown that patients with low flow/low gradient stenosis and borderline-normal ejection fraction (EF) are in an advanced stage of the disease because they have often developed a severe reduction in longitudinal myocardial function and in addition have pronounced myocardial replacement fibrosis due to cardiac remodelling despite a preserved EF. Therefore, aortic valve area, mean pressure gradient and EF alone cannot be taken into consideration for the management of patients with severe AS but a comprehensive assessment of the hemodynamics, such as stroke volume, special functional parameters as well as individual clinical appearance is essential for precise diagnostic and therapeutic decision making.

Entities:  

Mesh:

Year:  2012        PMID: 22736038     DOI: 10.1007/s00059-012-3640-y

Source DB:  PubMed          Journal:  Herz        ISSN: 0340-9937            Impact factor:   1.443


  33 in total

1.  Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology.

Authors:  Alec Vahanian; Helmut Baumgartner; Jeroen Bax; Eric Butchart; Robert Dion; Gerasimos Filippatos; Frank Flachskampf; Roger Hall; Bernard Iung; Jaroslaw Kasprzak; Patrick Nataf; Pilar Tornos; Lucia Torracca; Arnold Wenink
Journal:  Eur Heart J       Date:  2007-01-26       Impact factor: 29.983

2.  Strain analysis in patients with severe aortic stenosis and preserved left ventricular ejection fraction undergoing surgical valve replacement.

Authors:  Victoria Delgado; Laurens F Tops; Rutger J van Bommel; Frank van der Kley; Nina Ajmone Marsan; Robert J Klautz; Michel I M Versteegh; Eduard R Holman; Martin J Schalij; Jeroen J Bax
Journal:  Eur Heart J       Date:  2009-12       Impact factor: 29.983

3.  Aortic stenosis with severe left ventricular dysfunction and low transvalvular pressure gradients: risk stratification by low-dose dobutamine echocardiography.

Authors:  J L Monin; M Monchi; V Gest; A M Duval-Moulin; J L Dubois-Rande; P Gueret
Journal:  J Am Coll Cardiol       Date:  2001-06-15       Impact factor: 24.094

4.  Cooperative study on cardiac catheterization. Introduction.

Authors:  E Braunwald; R Gorlin; H D McIntosh; R S Ross; A M Rudolph; H J Swan
Journal:  Circulation       Date:  1968-05       Impact factor: 29.690

Review 5.  The natural history of aortic valve stenosis.

Authors:  D Horstkotte; F Loogen
Journal:  Eur Heart J       Date:  1988-04       Impact factor: 29.983

6.  Impact of global left ventricular afterload on left ventricular function in asymptomatic severe aortic stenosis: a two-dimensional speckle-tracking study.

Authors:  Patrizio Lancellotti; Erwan Donal; Julien Magne; Kim O'Connor; Marie L Moonen; Bernard Cosyns; Luc A Pierard
Journal:  Eur J Echocardiogr       Date:  2010-03-04

7.  Ventricular long-axis function is of major importance for long-term survival in patients with heart failure.

Authors:  B Grüner Sveälv; E L Olofsson; B Andersson
Journal:  Heart       Date:  2007-06-17       Impact factor: 5.994

8.  Increased cardiac expression of tissue inhibitor of metalloproteinase-1 and tissue inhibitor of metalloproteinase-2 is related to cardiac fibrosis and dysfunction in the chronic pressure-overloaded human heart.

Authors:  Stephane Heymans; Blanche Schroen; Pieter Vermeersch; Hendrik Milting; Fangye Gao; Astrid Kassner; Hilde Gillijns; Paul Herijgers; Willem Flameng; Peter Carmeliet; Frans Van de Werf; Yigal M Pinto; Stefan Janssens
Journal:  Circulation       Date:  2005-08-15       Impact factor: 29.690

9.  Paradoxical low-flow, low-gradient severe aortic stenosis despite preserved ejection fraction is associated with higher afterload and reduced survival.

Authors:  Zeineb Hachicha; Jean G Dumesnil; Peter Bogaty; Philippe Pibarot
Journal:  Circulation       Date:  2007-05-28       Impact factor: 29.690

10.  Midwall fibrosis is an independent predictor of mortality in patients with aortic stenosis.

Authors:  Marc R Dweck; Sanjiv Joshi; Timothy Murigu; Francisco Alpendurada; Andrew Jabbour; Giovanni Melina; Winston Banya; Ankur Gulati; Isabelle Roussin; Sadaf Raza; Nishant A Prasad; Rick Wage; Cesare Quarto; Emiliano Angeloni; Simone Refice; Mary Sheppard; Stuart A Cook; Philip J Kilner; Dudley J Pennell; David E Newby; Raad H Mohiaddin; John Pepper; Sanjay K Prasad
Journal:  J Am Coll Cardiol       Date:  2011-09-13       Impact factor: 24.094

View more
  3 in total

1.  The integrated value of sST2 and global longitudinal strain in the early stratification of patients with severe aortic valve stenosis: a translational imaging approach.

Authors:  Iacopo Fabiani; Lorenzo Conte; Nicola Riccardo Pugliese; Enrico Calogero; Valentina Barletta; Rossella Di Stefano; Tatiana Santoni; Cristian Scatena; Uberto Bortolotti; Antonio Giuseppe Naccarato; Anna Sonia Petronio; Vitantonio Di Bello
Journal:  Int J Cardiovasc Imaging       Date:  2017-06-29       Impact factor: 2.357

2.  [Therapy of aortic valve stenosis].

Authors:  J D Widder; J Bauersachs
Journal:  Internist (Berl)       Date:  2014-12       Impact factor: 0.743

3.  A novel cardiovascular magnetic resonance risk score for predicting mortality following surgical aortic valve replacement.

Authors:  Vassilios S Vassiliou; Menelaos Pavlou; Tamir Malley; Brian P Halliday; Vasiliki Tsampasian; Claire E Raphael; Gary Tse; Miguel Silva Vieira; Dominique Auger; Russell Everett; Calvin Chin; Francisco Alpendurada; John Pepper; Dudley J Pennell; David E Newby; Andrew Jabbour; Marc R Dweck; Sanjay K Prasad
Journal:  Sci Rep       Date:  2021-10-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.